Leksell Gamma Knife Perfexion. Image courtesy of Elekta.
January 21, 2015 — To provide high-quality, evidence-based cancer care throughout South Dakota, Minnesota and other surrounding states, Avera Health and Elekta announced a partnership to deploy Mosaiq oncology information system across the Avera Cancer Institute.
This partnership will enable Avera to implement an integrated oncology health system that spans the full cancer care continuum, from prevention and screening through to palliation and recovery.
The agreement includes Elekta linear accelerators (Versa HD, Elekta Infinity), Leksell Gamma Knife Perfexion and brachytherapy solutions, Monaco treatment planning and Metriq cancer registry software. All of the software will be deployed through a cloud-based solution.
"By choosing Elekta as our partner, we will be able to give our patients access to the world's most advanced technology for treating cancer," says Michael Peterson, M.D., radiation oncologist with Avera Health. "Having both Versa HD and Perfexion provides superior capabilities for stereotactic treatment delivery, enabling us to perform treatments faster, with even greater precision."
Cancer is the second leading cause of death in the United States and South Dakota,* which has a population of about 850,000. The agreement will benefit Avera's six regional locations and 40 outreach sites by driving further improvements in quality patient care.
For more information: www.elekta.com
May 30, 2024 
